Business
Comprehensive Healthcare Systems Announces Closing of Second and Final Tranche of Private Placement
Calgary, Alberta--(Newsfile Corp. - April 14, 2026) - Comprehensive Healthcare Systems Inc. (TSXV...
About this update from Comprehensive Healthcare Systems Inc
[{"type":"text","content":"Comprehensive Healthcare Systems Announces Closing of Second and Final Tranche of Private PlacementCalgary, Alberta--(Newsfile Corp. - April 14, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (OTCQB: CMHSF) (the \"Company\" or \"CHS\"), an industry leader in healthcare benefits administration software and services, is pleased to announce that it has closed the second tranche of its non-brokered private placement (the \"Offering\") announced on January 8, 2026, and updated January 26, February 12 and March 13, 2026, issuing an aggregate of 4,038,462 units (\"Units\") at $0.52 per Unit for aggregate gross proceeds of $2,100,000. Each Unit was comprised of one common share of the Company (\"Shares\") and one-half of a warrant, with a whole warrant (\"Warrants\") being exercisable to purchase one common share of the Company at an exercise price of $1.00 for a period of three years after closing. In connection with the second tranche, the Company paid aggregate finder fees of $32,217.62 in cash and issued an aggregate of 61,957 finder warrants exercisable to purchase one common share of the Company at an exercise price of $0.52 for a period of three years after closing. All securities issued are subject to a hold period until August 14, 2026.Insiders of the Company purchased 2,832,208 Units ($1,472,748) in the second tranche, representing 70.13% of the Units issued in the second tranche, with the associated common shares representing approximately 9.77% of the issued and outstanding shares upon closing, and assuming the deemed exercise of the associated warrants would then represent approximately 13.97% of the then issued and outstanding shares as of closing. The participation by insiders constitutes a \"related party transaction\" under the policies of the TSXV and Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (\"MI 61-101\"). The Company is relying upon the exemptions from the formal valuation and minority shareholder approval requirements contained in sections 5.5(a) (b) and (c), and 5.7(1)(a) and (b), respectively, of MI 61-101 on the basis that neither the fair market value of the subject matter of nor of the consideration for the transaction, insofar as it involves related parties, exceeds 25% of the issuer's market capitalization, and that no securities of th...